Stocks On the Run: U.S. Silica Holdings, Inc. (NYSE:SLCA), Ventas, Inc. (NYSE:VTR)

U.S. Silica Holdings, Inc. (NYSE:SLCA)

Credit Suisse Maintains U.S. Silica Holdings, Inc. (NYSE:SLCA)’s stock to Outperform with the price target of $18. This rating was issued on 10/24/18. The stock recently closed its previous session at $14.21 by showing a percentage change of 5.89% from its previous day closing price of $13.42.

Price Target is basically a projection of future price of a company’s stock by the expert analysis of investment analysts or investment firms. There may be various price targets for a stock. These analysts and investment firms use various valuation methods to decide a price target for a stock.

Several investment firms issued their expert ratings on U.S. Silica Holdings, Inc. (NYSE:SLCA) in which Barclays Maintains U.S. Silica Holdings, Inc. (NYSE:SLCA) to Overweight by settling a price target of $20 on 10/24/18. Citigroup Maintains the stock to Neutral on 10/24/18 by stationing a price target of $15. Jefferies Downgrades the company’s stock to Hold on 10/17/18 by setting a price target of $20. Morgan Stanley Downgrades U.S. Silica Holdings, Inc. (NYSE:SLCA) to Underweight with no specific Price Target.

U.S. Silica Holdings, Inc. (NYSE:SLCA) currently has a consensus Price Target of $20.05. While some analysts have a High Price target for the stock of $31 and a Low Price Target of $12.5.

Several sell side analysts reviewed their recommendations on U.S. Silica Holdings, Inc. (NYSE:SLCA) where 4 analyst have rated the stock as Strong Buy, 10 analysts said it’s a Buy, 6 rated the stock as Hold, 0 analysts reported Underperform and 0 analysts gave their recommendations as Sell. (Current Month Yahoo Finance Ratings)

Zacks Investment Research also rated the stock with a value of 2.18. This scale runs from 1 to 5 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, U.S. Silica Holdings, Inc. (NYSE:SLCA) reported its Actual EPS of $0.44/share. The analysts offering Earnings Estimates for the company were believing that U.S. Silica Holdings, Inc. (NYSE:SLCA) could bring EPS of $0.59/share. The difference between Actual EPS and Estimated EPS was -0.15 Percent. Thus the company showed an Earnings Surprise of -25.4 Percent.

U.S. Silica Holdings, Inc. (NYSE:SLCA) has a market capitalization of 1.1 Billion. The stock traded with the volume of 4.35 Million shares in the last trading session. The stock touched its high share price of $38.70 on 01/11/18 and the stock also touched its Lowest price in the last 52-weeks of trading on 10/23/18 as $12.89. The company has a 1 Year high price target of $21.48. The stock is currently trading with a distance of 20-Day Simple Moving Average (SMA20) of -20.3%. The Moving Average SMA50 is -27.7% while SMA200 is -46.27%.

U.S. Silica Holdings, Inc. (NYSE:SLCA) is currently showing its ROA (Return on Assets) of 4.6%. The Return on Investment (ROI) is at 7.4% while it’s Return on Equity (ROE) value stands at 9.3%. The stock currently shows its YTD (Year to Date) performance of -56.36 percent while its Weekly performance value is -11.57%. The Monthly and Yearly performances are -22.6 percent and -49.59 percent respectively. The Relative Volume value measured for U.S. Silica Holdings, Inc. (NYSE:SLCA) is 1.59. The Average Volume (3 months) is 2.73 Million.

The stock currently has its Annual Dividend of $0.25 and an annual Dividend Yield of 1.76 Percent. SLCA has P/E (Price to Earnings ttm) value of 12.5, Forward P/E of 11.52, P/C (Price to cash per share) of 3.01 and Price to Free Cash Flow (P/FCF) value of 0. The stock is showing its Operating Margin of 10.1 percent.

Company Profile:

U.S. Silica Holdings, Inc. is a producer of industrial minerals, including sand proppants, whole grain silica, ground silica, fine ground silica, calcined kaolin clay and aplite clay. The company also operates as a research and development specialist for customized products and solutions. The industries and applications served by U.S. Silica includes oil and gas, glass, chemicals, foundry, building products, fillers and extenders, recreation, industrial filtration and treatment, and testing and analysis. U.S. Silica Holdings, Inc. is headquartered in Frederick, Maryland.

Ventas, Inc. (NYSE:VTR)

Bank of America Maintains Ventas, Inc. (NYSE:VTR)’s stock to Neutral with the price target of $60. This rating was issued on 7/10/18. The stock recently closed its previous session at $56.79 by showing a percentage change of -0.19% from its previous day closing price of $56.9.

Price Target is basically a projection of future price of a company’s stock by the expert analysis of investment analysts or investment firms. There may be various price targets for a stock. These analysts and investment firms use various valuation methods to decide a price target for a stock.

Several investment firms issued their expert ratings on Ventas, Inc. (NYSE:VTR) in which Cantor Fitzgerald Initiates Coverage On Ventas, Inc. (NYSE:VTR) to Neutral by settling a price target of $56 on 6/04/18. Evercore ISI Group Downgrades the stock to Underperform on 5/21/18 with no specific Price Target. BMO Capital Upgrades the company’s stock to Market Perform on 4/30/18 with no specific Price Target. KeyBanc Maintains Ventas, Inc. (NYSE:VTR) to Underweight with a price target of $43.

Ventas, Inc. (NYSE:VTR) currently has a consensus Price Target of $56.47. While some analysts have a High Price target for the stock of $63 and a Low Price Target of $43.

Several sell side analysts reviewed their recommendations on Ventas, Inc. (NYSE:VTR) where 0 analyst have rated the stock as Strong Buy, 2 analysts said it’s a Buy, 13 rated the stock as Hold, 4 analysts reported Underperform and 0 analysts gave their recommendations as Sell. (Current Month Yahoo Finance Ratings)

Zacks Investment Research also rated the stock with a value of 3.27. This scale runs from 1 to 5 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Ventas, Inc. (NYSE:VTR) reported its Actual EPS of $0.46/share. The analysts offering Earnings Estimates for the company were believing that Ventas, Inc. (NYSE:VTR) could bring EPS of $0.37/share. The difference between Actual EPS and Estimated EPS was 0.09 Percent. Thus the company showed an Earnings Surprise of 24.3 Percent.

Ventas, Inc. (NYSE:VTR) has a market capitalization of 20.38 Billion. The stock traded with the volume of 4.34 Million shares in the last trading session. The stock touched its high share price of $65.72 on 11/14/17 and the stock also touched its Lowest price in the last 52-weeks of trading on 04/25/18 as $46.55. The company has a 1 Year high price target of $56.06. The stock is currently trading with a distance of 20-Day Simple Moving Average (SMA20) of 4.22%. The Moving Average SMA50 is 0.09% while SMA200 is 4.96%.

Ventas, Inc. (NYSE:VTR) is currently showing its ROA (Return on Assets) of 5.3%. The Return on Investment (ROI) is at 4.8% while it’s Return on Equity (ROE) value stands at 11.4%. The stock currently shows its YTD (Year to Date) performance of -5.37 percent while its Weekly performance value is 1.52%. The Monthly and Yearly performances are 5.24 percent and -7.05 percent respectively. The Relative Volume value measured for Ventas, Inc. (NYSE:VTR) is 2.01. The Average Volume (3 months) is 2.16 Million.

The stock currently has its Annual Dividend of $3.16 and an annual Dividend Yield of 5.56 Percent. VTR has P/E (Price to Earnings ttm) value of 40.68, Forward P/E of 36.47, P/C (Price to cash per share) of 216.45 and Price to Free Cash Flow (P/FCF) value of 76.48. The stock is showing its Operating Margin of 27.9 percent.

Company Profile:

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to Ventas or the Company mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted.